Shuttle Pharmaceuticals Holdings Net Debt Growth & History (SHPH)
Shuttle Pharmaceuticals Holdings's net debt was −$101,858 for fiscal 2025.
View full Shuttle Pharmaceuticals Holdings company overviewShuttle Pharmaceuticals Holdings annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$101,858 | $1.5M | — |
| 2024 | 2024-12-31 | −$1.6M | $2,664 | — |
| 2023 | 2023-12-31 | −$1.6M | $6.7M | — |
| 2022 | 2022-12-31 | −$8.4M | −$8.1M | — |
| 2021 | 2021-12-31 | −$284,352 | — | — |
Shuttle Pharmaceuticals Holdings quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | −$875,933 | $3.4M | — |
| Q4 2025 | 2025-12-31 | −$101,858 | $1.5M | — |
| Q3 2025 | 2025-09-30 | −$1.8M | −$2.0M | — |
| Q2 2025 | 2025-06-30 | −$4.6M | −$5.0M | — |
| Q1 2025 | 2025-03-31 | −$4.2M | −$4.1M | — |
| Q4 2024 | 2024-12-31 | −$1.6M | $2,664 | — |
| Q3 2024 | 2024-09-30 | $157,601 | $3.1M | — |
| Q2 2024 | 2024-06-30 | $459,758 | $5.1M | — |
| Q1 2024 | 2024-03-31 | −$114,076 | $7.0M | — |
| Q4 2023 | 2023-12-31 | −$1.6M | $6.7M | — |
| Q3 2023 | 2023-09-30 | −$2.9M | $6.1M | — |
| Q2 2023 | 2023-06-30 | −$4.7M | — | — |
| Q1 2023 | 2023-03-31 | −$7.1M | — | — |
| Q4 2022 | 2022-12-31 | −$8.4M | −$8.1M | — |
| Q3 2022 | 2022-09-30 | −$9.0M | — | — |
| Q4 2021 | 2021-12-31 | −$284,352 | — | — |
Shuttle Pharmaceuticals Holdings net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Shuttle Pharmaceuticals Holdings's net debt increased from −$284,352 to −$101,858, a change of $182,494. The latest reported quarter, Q1 2026, shows −$875,933.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Shuttle Pharmaceuticals Holdings source filings ↗